Pahayahay, Rhea Jane M.

HRN: 06-87-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
METRONIDAZOLE 500MG (TAB)
02/19/2026
02/26/2026
ORAL
500mg
TID
Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines